Here are four things to know:
1. Evidera, headquartered in Bethesda, Md., allows real-time analyses of claims, electronic medical records and registry data.
2. Evalytica has pre-built Analysis Apps with analytic capabilities in drug safety, epidemiology, health economics and comparative effectiveness.
3. A library of reusable patient cohort and health outcome definitions allow Evalytica to create collaboration and sharing based on common interest.
4. Users can ask Evidera scientists for assistance with database selection, cohort definition and analysis methodology.
“Evalytica marks a new frontier of Evidera as a leader in technology enabled tools for generating and communicating evidence of product safety and effectiveness,” said Jon Williams, president and CEO, Evidera.
More articles on quality & infection control:
Underestimated cause of bone & joint infections needs to be treated aggressively: 6 things to know from new research
Researchers find link between virus and cancerous tumors — 5 things to know
Nutritional deficiencies prevalent in 20%+ of bariatric patients: 5 insights
